MS4A8
gene geneOn this page
Also known as MS4A4CD20L5
Summary
MS4A8 (membrane spanning 4-domains A8, HGNC:13380) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 8 (Q9BY19). May be involved in signal transduction as a component of a multimeric receptor complex.
This gene encodes a member of the membrane-spanning 4A gene family. Members of this protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. The gene encoding this protein is localized to 11q12.3, among a cluster of family members.
Source: NCBI Gene 83661 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_031457
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13380 |
| Approved symbol | MS4A8 |
| Name | membrane spanning 4-domains A8 |
| Location | 11q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MS4A4, CD20L5 |
| Ensembl gene | ENSG00000166959 |
| Ensembl biotype | protein_coding |
| OMIM | 606549 |
| Entrez | 83661 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 5 protein_coding, 5 retained_intron, 1 nonsense_mediated_decay
ENST00000300226, ENST00000450141, ENST00000525458, ENST00000529752, ENST00000532816, ENST00000532953, ENST00000533354, ENST00000533691, ENST00000534316, ENST00000855861, ENST00000855862
RefSeq mRNA: 1 — MANE Select: NM_031457
NM_031457
CCDS: CCDS7990
Canonical transcript exons
ENST00000300226 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001108190 | 60699612 | 60699775 |
| ENSE00001108195 | 60708650 | 60708781 |
| ENSE00001108198 | 60715310 | 60715807 |
| ENSE00003484962 | 60703378 | 60703500 |
| ENSE00003551899 | 60700860 | 60701079 |
| ENSE00003611485 | 60706988 | 60707047 |
| ENSE00003654964 | 60715021 | 60715134 |
Expression profiles
Bgee: expression breadth ubiquitous, 143 present calls, max score 99.55.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.4483 / max 500.7696, expressed in 92 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114487 | 0.8254 | 54 |
| 114488 | 0.1850 | 29 |
| 114486 | 0.1576 | 38 |
| 114490 | 0.1336 | 22 |
| 114489 | 0.0806 | 18 |
| 114485 | 0.0661 | 31 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 99.55 | gold quality |
| bronchial epithelial cell | CL:0002328 | 99.40 | gold quality |
| ileal mucosa | UBERON:0000331 | 99.02 | gold quality |
| bronchus | UBERON:0002185 | 98.80 | gold quality |
| jejunal mucosa | UBERON:0000399 | 97.76 | gold quality |
| duodenum | UBERON:0002114 | 94.62 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.71 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 91.98 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 90.69 | gold quality |
| small intestine | UBERON:0002108 | 89.49 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 88.40 | silver quality |
| fallopian tube | UBERON:0003889 | 87.78 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.61 | gold quality |
| pancreatic ductal cell | CL:0002079 | 87.55 | silver quality |
| rectum | UBERON:0001052 | 86.98 | gold quality |
| right lung | UBERON:0002167 | 86.15 | gold quality |
| trachea | UBERON:0003126 | 85.95 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 83.52 | gold quality |
| nasopharynx | UBERON:0001728 | 83.51 | gold quality |
| gall bladder | UBERON:0002110 | 83.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.45 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 78.69 | gold quality |
| transverse colon | UBERON:0001157 | 77.55 | gold quality |
| jejunum | UBERON:0002115 | 76.57 | gold quality |
| pituitary gland | UBERON:0000007 | 76.51 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.44 | gold quality |
| colonic mucosa | UBERON:0000317 | 76.35 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 76.19 | gold quality |
| endometrium | UBERON:0001295 | 75.43 | gold quality |
| left uterine tube | UBERON:0001303 | 75.17 | gold quality |
Single-cell (SCXA)
Detected in 9 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 68.79 |
| E-CURD-114 | yes | 64.95 |
| E-HCAD-1 | yes | 28.90 |
| E-GEOD-130148 | yes | 14.84 |
| E-MTAB-5061 | yes | 12.28 |
| E-GEOD-81608 | yes | 9.94 |
| E-ENAD-27 | yes | 4.78 |
| E-GEOD-83139 | no | 3.30 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting MS4A8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-4499 | 99.62 | 67.29 | 1470 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-133A-3P | 99.27 | 71.53 | 1270 |
| HSA-MIR-133B | 99.27 | 71.53 | 1270 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-4326 | 98.97 | 67.63 | 962 |
| HSA-MIR-138-2-3P | 98.91 | 68.33 | 1643 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-384 | 98.71 | 67.34 | 1229 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-1233-5P | 98.19 | 66.71 | 1201 |
| HSA-MIR-6778-5P | 98.19 | 66.59 | 1239 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-194-3P | 97.36 | 65.96 | 1027 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
Literature-anchored findings (GeneRIF, showing 1)
- MS4A8B is a novel differentiation marker of the intestinal epithelium that supports the maintenance of a physiological barrier function in the gut by modulating the transcriptome and by conferring an increased resistance to reactive oxygen species. (PMID:23348583)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ms4a8a | ENSMUSG00000024730 |
| rattus_norvegicus | Ms4a8 | ENSRNOG00000020939 |
Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)
Protein
Protein identifiers
Membrane-spanning 4-domains subfamily A member 8 — Q9BY19 (reviewed: Q9BY19)
Alternative names: Four-span transmembrane protein 4, Membrane-spanning 4-domains subfamily A member 8B
All UniProt accessions (4): Q9BY19, E9PJN8, E9PQE1, H0YD94
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in signal transduction as a component of a multimeric receptor complex.
Subcellular location. Membrane.
Tissue specificity. Expressed by hematopoietic tissues and cells lines.
Similarity. Belongs to the MS4A family.
RefSeq proteins (1): NP_113645* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
| IPR030417 | MS4A | Family |
Pfam: PF04103
UniProt features (12 total): topological domain 5, transmembrane region 4, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BY19-F1 | 71.55 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 65 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, SABATES_COLORECTAL_ADENOMA_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN, FEVR_CTNNB1_TARGETS_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ZNF843_TARGET_GENES, GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN, MIR4778_3P, MIR4499, MIR384, GSE13306_RA_VS_UNTREATED_TCONV_DN, GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP, GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP
GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)
GO Molecular Function (0):
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
406 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MS4A8 | MS4A6E | Q96DS6 | 921 |
| MS4A8 | MS4A4E | Q96PG1 | 713 |
| MS4A8 | CD2AP | Q9Y5K6 | 662 |
| MS4A8 | ABCA7 | Q8IZY2 | 621 |
| MS4A8 | SORL1 | Q92673 | 599 |
| MS4A8 | EPHA1 | P21709 | 599 |
| MS4A8 | PICALM | Q13492 | 595 |
| MS4A8 | CLU | P10909 | 569 |
| MS4A8 | MS4A6A | Q9H2W1 | 544 |
| MS4A8 | CD33 | P20138 | 521 |
| MS4A8 | ZCWPW1 | Q9H0M4 | 513 |
| MS4A8 | BIN1 | O00499 | 512 |
| MS4A8 | NME8 | Q8N427 | 480 |
| MS4A8 | CASS4 | Q9NQ75 | 480 |
| MS4A8 | SLC24A4 | Q8NFF2 | 470 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0A7EPL0, A2RV66, A4QP16, A6QPF4, C4QM85, F4JYG0, O35892, P11836, P13386, P19437, P20490, P41739, P53762, P56645, P70326, P79778, Q01362, Q148B6, Q29131, Q3C1V0, Q3C2E2, Q3SA47, Q3UNB8, Q3V3Q4, Q3YBM2, Q5I2P1, Q5JT82, Q5R8D6, Q5R8E0, Q60HE7, Q68FU0, Q6A058, Q8BVM2, Q8N1N2, Q8NDZ0, Q8QGQ8, Q8WUU8, Q920C4, Q92540, Q96HJ5
Diamond homologs: A6QPF4, P11836, P13386, P19437, P20490, Q01362, Q3C1V0, Q3C2E2, Q3UPL6, Q8N5U1, Q920C4, Q96JA4, Q96JQ5, Q99N05, Q99N07, Q99N09, Q99N10, Q9BY19, Q9H2W1, Q9H3V2, Q9NXJ0, Q96HJ5, Q99N08, Q5REZ6, Q96PG2, Q9GZW8, Q99N03, Q96PG1, Q96DS6, Q2YDM3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1605 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:60708680:A:C | S145R | 0.993 |
| 11:60708682:T:A | S145R | 0.993 |
| 11:60708682:T:G | S145R | 0.993 |
| 11:60706988:T:C | F115L | 0.988 |
| 11:60706990:T:A | F115L | 0.988 |
| 11:60706990:T:G | F115L | 0.988 |
| 11:60703397:G:A | G80D | 0.984 |
| 11:60703477:T:C | F107L | 0.983 |
| 11:60703479:T:A | F107L | 0.983 |
| 11:60703479:T:G | F107L | 0.983 |
| 11:60703486:T:A | W110R | 0.983 |
| 11:60703486:T:C | W110R | 0.983 |
| 11:60703396:G:C | G80R | 0.982 |
| 11:60707001:G:A | G119E | 0.982 |
| 11:60708689:T:C | C148R | 0.982 |
| 11:60703417:G:C | G87R | 0.980 |
| 11:60708701:G:A | G152R | 0.980 |
| 11:60708701:G:C | G152R | 0.980 |
| 11:60701077:G:T | G73W | 0.978 |
| 11:60708673:C:A | N142K | 0.975 |
| 11:60708673:C:G | N142K | 0.975 |
| 11:60703418:G:A | G87D | 0.974 |
| 11:60715060:T:C | C192R | 0.972 |
| 11:60708702:G:A | G152E | 0.971 |
| 11:60703492:G:C | G112R | 0.970 |
| 11:60707000:G:A | G119R | 0.970 |
| 11:60707000:G:C | G119R | 0.970 |
| 11:60703498:T:A | W114R | 0.969 |
| 11:60703498:T:C | W114R | 0.969 |
| 11:60701077:G:A | G73R | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000290058 (11:60710170 C>G), RS1000405815 (11:60710437 G>A), RS1000418375 (11:60704799 A>C,T), RS1000509730 (11:60709495 C>T), RS1000606226 (11:60703282 T>C,G), RS1000661361 (11:60714792 G>A), RS1000775540 (11:60714990 C>A,T), RS1000911788 (11:60698384 T>C), RS1001184002 (11:60704317 C>T), RS1001303908 (11:60705563 G>A), RS1001729848 (11:60697939 A>T), RS1001746177 (11:60710559 G>C), RS1001793222 (11:60714452 A>G), RS1002100143 (11:60710939 C>T), RS1002283635 (11:60704726 C>G)
Disease associations
OMIM: gene MIM:606549 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_VD91 | 300-19 GFP-MS4A8B | Cancer cell line | |
| CVCL_VD96 | BJAB GFP-MS4A8B | Cancer cell line | Female |
| CVCL_VE01 | BJAB HA-MS4A8B | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.